Atome Plc (LON:ATOM – Get Free Report)’s share price was down 1% during mid-day trading on Thursday . The company traded as low as GBX 59.55 and last traded at GBX 60. Approximately 412,013 shares changed hands during trading, an increase of 20% from the average daily volume of 342,095 shares. The stock had previously closed at GBX 60.60.
Wall Street Analysts Forecast Growth
Separately, Canaccord Genuity Group dropped their target price on shares of Atome from GBX 140 to GBX 115 and set a “speculative buy” rating for the company in a report on Friday. Two equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of GBX 122.50.
View Our Latest Stock Analysis on ATOM
Atome Price Performance
Insider Transactions at Atome
In other news, insider James E. C. Spalding (Hellmers) acquired 198,347 shares of the company’s stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average price of GBX 60 per share, with a total value of £119,008.20. Also, insider Robert Anthony Sheffrin acquired 57,482 shares of the company’s stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average cost of GBX 60 per share, with a total value of £34,489.20. Insiders have bought a total of 5,480,563 shares of company stock valued at $328,833,780 in the last three months. 38.52% of the stock is currently owned by corporate insiders.
About Atome
ATOME PLC is the first green fertiliser production company listed on the UK market with large-scale production planned in Paraguay and Costa Rica, targeting the fast-growing global demand for green products.
Further Reading
- Five stocks we like better than Atome
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Atome Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atome and related companies with MarketBeat.com's FREE daily email newsletter.
